Update on the Observational Gastroenteropancreatic Neuroendocrine Tumors (GEPNET) Registry: An International Collaboration

#505

Introduction: Awareness of, and epidemiologic data for, GEPNETs is lacking in many geographic areas.

Aim(s): To study prevalence, incidence, regional trends in diagnosis, and clinical management of GEPNET in the Asia-Pacific, Middle East, Turkey and South Africa.

Materials and methods: Patients (pts) with histopathological diagnosis of GEPNETs within five yrs before registry entry were included. Pro- and retrospective data were collected at 82 sites. Enrollment began in Jul-09 and is ongoing. Follow-up will be for five yrs.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Yalçin S, Grozinsky-Glasberg S, Aykan N, Serdengeçti S, Saglam S,

Keywords: gep-net,